Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle I Silver

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Preventive Medicine Reports|June 26, 2023
Factors associated with shorter-interval cervical cancer screening for young women in three United States healthcare systemsAnne Marie McCarthy, Jasmin A Tiro, Ellen Hu, et al.
JAMA Network Open|February 26, 2026
A Multicomponent Strategy to Increase Human Papillomavirus Vaccination Rates in Primary Care: A Cluster Randomized Clinical TrialRuoyun Wang, Lei Liu, Sherry Dodd, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 2, 2022
Estimating Cancer Screening Sensitivity and Specificity Using Healthcare Utilization Data: Defining the Accuracy Assessment IntervalJessica Chubak, Andrea N Burnett-Hartman, William E Barlow, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 23, 2024
Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare SettingsDavid Cheng, Meghan L Rieu-Werden, Jacquelyn M Lykken, et al.
Preventive Medicine|November 11, 2021
Variation in the receipt of human papilloma virus co-testing for cervical screening: Individual, provider, facility and healthcare system characteristicsJennifer S Haas, David Cheng, Liyang Yu, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 14, 2018
Clinical Outcomes after Conservative Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) in Women Ages 21-39 YearsMichelle I Silver, Julia C Gage, Mark Schiffman, et al.
JAMA Network Open|January 17, 2025
Delivering Guideline-Concordant Care for Patients With High-Risk HPV and Normal Cytologic FindingsJasmin A Tiro, Jacquelyn M Lykken, Patricia M Chen, et al.
Preventive Medicine|March 8, 2021
Achieving equity in cervical cancer screening in low- and middle-income countries (LMICs): Strengthening health systems using a systems thinking approachPatti E Gravitt, Michelle I Silver, Heather M Hussey, et al.
JNCI Cancer Spectrum|December 5, 2022
Provider beliefs in effectiveness and recommendations for primary HPV testing in 3 health-care systemsGina R Kruse, Jacquelyn M Lykken, Eric J Kim, et al.
Journal of General Internal Medicine|May 30, 2025
Barriers to the Equitable Implementation of Risk-Based Cervical Cancer Management GuidelinesCheryl R Clark, Jacquelyn M Lykken, Patricia M Chen, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Preventive Medicine Reports|June 26, 2023
Factors associated with shorter-interval cervical cancer screening for young women in three United States healthcare systemsAnne Marie McCarthy, Jasmin A Tiro, Ellen Hu, et al.
JAMA Network Open|February 26, 2026
A Multicomponent Strategy to Increase Human Papillomavirus Vaccination Rates in Primary Care: A Cluster Randomized Clinical TrialRuoyun Wang, Lei Liu, Sherry Dodd, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 2, 2022
Estimating Cancer Screening Sensitivity and Specificity Using Healthcare Utilization Data: Defining the Accuracy Assessment IntervalJessica Chubak, Andrea N Burnett-Hartman, William E Barlow, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 23, 2024
Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare SettingsDavid Cheng, Meghan L Rieu-Werden, Jacquelyn M Lykken, et al.
Preventive Medicine|November 11, 2021
Variation in the receipt of human papilloma virus co-testing for cervical screening: Individual, provider, facility and healthcare system characteristicsJennifer S Haas, David Cheng, Liyang Yu, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 14, 2018
Clinical Outcomes after Conservative Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) in Women Ages 21-39 YearsMichelle I Silver, Julia C Gage, Mark Schiffman, et al.
JAMA Network Open|January 17, 2025
Delivering Guideline-Concordant Care for Patients With High-Risk HPV and Normal Cytologic FindingsJasmin A Tiro, Jacquelyn M Lykken, Patricia M Chen, et al.
Preventive Medicine|March 8, 2021
Achieving equity in cervical cancer screening in low- and middle-income countries (LMICs): Strengthening health systems using a systems thinking approachPatti E Gravitt, Michelle I Silver, Heather M Hussey, et al.
JNCI Cancer Spectrum|December 5, 2022
Provider beliefs in effectiveness and recommendations for primary HPV testing in 3 health-care systemsGina R Kruse, Jacquelyn M Lykken, Eric J Kim, et al.
Journal of General Internal Medicine|May 30, 2025
Barriers to the Equitable Implementation of Risk-Based Cervical Cancer Management GuidelinesCheryl R Clark, Jacquelyn M Lykken, Patricia M Chen, et al.
Pageof 5